<?xml version="1.0" encoding="UTF-8"?>
<p>CEPI has established multiple partnering agreements that make up its current portfolio of 19 priority pathogen vaccine candidates and three rapid response platforms that reflect a potential investment of over US$450 million. Additional partnerships are under negotiation. Table 
 <xref rid="Tab2" ref-type="table">2</xref> provides some details of the CEPI vaccine portfolio. These details are also provided on the CEPI website (
 <ext-link ext-link-type="uri" xlink:href="http://www.cepi.net" xmlns:xlink="http://www.w3.org/1999/xlink">www.cepi.net</ext-link>).
</p>
